Trial Profile
Study of the efficacy and safety of ramelteon in insomnia of diabetes merger under the medical treatment of cancer patients
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 07 Jun 2019
Price :
$35
*
At a glance
- Drugs Ramelteon (Primary)
- Indications Insomnia
- Focus Therapeutic Use
- 04 Jun 2019 Status changed from recruiting to discontinued.
- 24 Jul 2014 New trial record